- This event has passed.
6th APP, Nursing and Primary Care Liver Conference
May 21, 2022 @ 7:30 am – 4:30 pm
The conference will focus on highlighting new standards in diagnosis and clinical management of liver diseases for the non-liver specialist. The educational format includes lectures, case studies and panel discussion.
18603 La Cantera Terrace
San Antonio, Texas 78256 United States
Physicians (MD or DO): $99
Other healthcare professionals (NP, PA, RN, PharmD, others): $69
Students (limited registrations): Free*
* A limited number of free registrations will be given to full time students.
In order to be considered, students must email firstname.lastname@example.org and provide the university, name of program, degree being pursued and expected graduation year.
|7:30-8:15 AM||Buffet breakfast (Grand Foyer)|
Non-accredited Product Theater: Addressing Uncertainties With Confidence (Nadege Gunn, MD; Sponsored by Gilead Sciences) (Incanto Ballroom)
|8:15-8:25 AM||Conference welcome|
|8:25-8:30 AM||Completion of pre-test questions|
|8:30-8:55 AM||Liver cell death and regeneration: Understanding the mystery of the liver (Fred Poordad, MD)|
|8:55-9:20 AM||Fatty liver: When is it benign and who needs to be concerned? (Eric Lawitz, MD)|
|9:20-9:45 AM||Truths and myths surrounding drug induced liver injury: Prescription, OTC and holistic therapies (Fabian Rodas, MD)|
|9:45-10:15 AM||Q&A/panel discussion|
|10:15-10:30 AM||Break (Grand Foyer)|
|10:30-11:00 AM||Mystery case presentation (Interactive case) (Anthony Derencius, PA-C & Josh Pingleton, FNP-C)|
|11:00-11:45 AM||My patient has cirrhosis: 7 things I need to remember (Katherine Crow, PA-C)|
|11:45 AM-12:05 PM||Q&A/panel discussion|
|12:05-12:55 PM||Lunch (Grand Foyer)|
|12:55-2:25 PM||Hepatocellular carcinoma (HCC) case study: What you don’t know can hurt your patient|
12:55-1:05 PM Case presentation (Katherine Crow, PA-C)
1:05-1:35 PM Epidemiology, diagnosis and medical management options (Shruti Pandita, MD)
1:35-2:00 PM Surgery is often the best therapy (Danielle Fritze, MD)
2:00-2:25 PM Sometimes two surgeries are better than one (Seiji Yamaguchi, MD)
|2:25-2:40 PM||Q&A/panel discussion|
|2:40-2:55 PM||Break (Grand Foyer)|
|2:55-3:25 PM||Understanding viral hepatitis lab results, screening, vaccinating and treating (Kim Hinojosa, FNP-C)|
|3:25-3:55 PM||Trivial Pursuit: Liver conditions you probably never heard of (Fred Poordad, MD)|
|3:55-4:20 PM||Q&A/panel discussion|
|4:20-4:25 PM||Review correct answers for pre/post test questions|
|4:25-4:30 PM||Meeting wrap-up/closing remarks|
Jointly Provided By:
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of UT Health Science Center San Antonioand the Texas Liver Institute. UT Health Science Center San Antonio is accredited by theAccreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
UT Health Science Center San Antonio designates this live activity up to a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation.
The University of Texas Health Science Center at San Antonio is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Criteria for Successful Completion: Contact hours will be awarded for the sessions attended. Up to 7.25 contact hours may be earned by registered nurses who successfully complete this continuing education activity.
Certificate of Attendance
Healthcare professionals will receive a certificate of attendance and should consult with their licensing board for information on applicability and acceptance.
This continuing medical education activity is partially funded by independent medical educational grants procured by UT Health San Antonio School of Medicine, Office of Continuing Medical Education: Mallinckrodt Pharmaceuticals, Mirum and Salix Pharmaceuticals, Inc.